Recruiting OBSERVATIONAL NCT05018663

Artificial Intelligence (AI) Cytopathology Trial

Artificial Intelligence for Rapid On-site Evaluation (AI-ROSE) for Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA) Biopsy of Pancreatic Solid Lesions: A Prospective Double Blinded Study

Sponsor: The University of Texas Health Science Center, Houston

Conditions Pancreatic Solid Lesions

Interventions Artificial Intelligence software ROSE

Updated 5 times since 2021 Last updated: Feb 15, 2023 Started: Jul 21, 2021 Primary completion: Jul 31, 2024 Completion: Jan 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05018663, this observational or N/A phase trial focuses on Pancreatic Solid Lesions and remains actively recruiting participants. Sponsored by The University of Texas Health Science Center, Houston, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2023 — Jul 2024 [monthly]

Recruiting
Oct 2021 — Mar 2023 [monthly]

Recruiting
Sep 2021 — Oct 2021 [monthly]

Recruiting

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Texas Health Science Center, Houston

Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States